Scandinavian Real Heart AB (Publ) (STO:HEART)

Market Cap	154.24M +100.4%
Revenue (ttm)	153.10K +7,832.5%
Net Income	-35.50M
EPS	-7.10
Shares Out	8.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,139
Average Volume	17,217
Open	18.15
Previous Close	17.60
Day's Range	17.25 - 18.90
52-Week Range	12.10 - 30.00
Beta	1.13
RSI	67.44
Earnings Date	May 25, 2026

About STO:HEART

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 15
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: HEART

Financial Performance

In 2025, STO:HEART's revenue was 153,098, an increase of 7832.54% compared to the previous year's 1,930. Losses were -35.50 million, 3.34% more than in 2024.